Tinnitus; headache; This is a spontaneous report from a contactable other Health Professional (patient). A 37-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284), via an unspecified route of administration on 09Jan2021 10:00 at single dose in right arm for covid-19 immunization. Medical history included chronic pain, hypothyroidism and anxiety, allergies to medications, food, or other products included sulfa.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included levothyroxine, eszopiclone (LUNESTA), ibuprofen (MOTRIN), celecoxib (CELEXA). Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. No treatment was received. The patient experienced tinnitus and headache on 11Jan2021. The outcome of the events was recovering.